CelGro® Facilitates Lymphatic Vessel Regeneration
- Breakthrough tissue engineering combining CelGro® with lymphatic and blood vessel cells to create functional lymphatic tissue published in PNAS
- Substantial advance in the fabrication of implantable lymphatic grafts which could have significant implications for a novel and effective surgical treatment of lymphedema
- Further validates CelGro® asthe ideal collagen scaffold that can be used on its own or in combination with cells to fabricate complex tissue grafts to replace damaged tissue or augment repair of defects
- Collaboration between Professor Shulamit Levenberg at the Israel Institute of Technology and Orthocell’s Professor Minghao Zheng at the Perron Institute and the University of Western Australia
http://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02402507-6A1044035?access_token=83ff96335c2d45a094df02a206a39ff4
http://www.*.com.au/companies/news/926761/orthocell-makes-progress-with-portfolio-of-celgro-products-within-the-bone-tendon-and-nerve-space-926761.html
http://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02402716-6A1044121?access_token=83ff96335c2d45a094df02a206a39ff4
http://www.orthocell.com.au/publications-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
0.050(4.46%) |
Mkt cap ! $294.3M | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.20 | $1.13 | $361.9K | 309.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 5556 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 10214 | 6 |
View Market Depth
| Last trade - 11.21am 19/09/2025 (20 minute delay) ? |
| OCC (ASX) Chart |